147 related articles for article (PubMed ID: 23979366)
21. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545
[No Abstract] [Full Text] [Related]
22. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
[TBL] [Abstract][Full Text] [Related]
23. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
[TBL] [Abstract][Full Text] [Related]
24. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
[TBL] [Abstract][Full Text] [Related]
25. The obstacles that should be overcome to develop new anticoagulants for severe sepsis.
Iba T
Crit Care Med; 2014 Mar; 42(3):e248-9. PubMed ID: 24534987
[No Abstract] [Full Text] [Related]
26. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
[TBL] [Abstract][Full Text] [Related]
27. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
Masuda S; Adachi O; Ito K; Matsuo S; Hayatsu Y; Suzuki Y; Saito T; Akiyama M; Kumagai K; Motoyoshi N; Kawamoto S; Saiki Y
Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
[TBL] [Abstract][Full Text] [Related]
28. Effective control of relapsing disseminated intravascular coagulation in a patient with decompensated liver cirrhosis by recombinant soluble thrombomodulin.
Hasebe T; Sawada K; Nakajima S; Maeda S; Abe M; Suzuki Y; Ohtake T; Hasebe C; Fujiya M; Kohgo Y
Intern Med; 2014; 53(1):29-33. PubMed ID: 24390524
[TBL] [Abstract][Full Text] [Related]
29. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.
Koga T; Inoue D; Okada A; Aramaki T; Yamasaki S; Nakashima M; Kawakami A; Eguchi K
Rheumatol Int; 2011 Dec; 31(12):1657-9. PubMed ID: 21240494
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
[TBL] [Abstract][Full Text] [Related]
32. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
[TBL] [Abstract][Full Text] [Related]
33. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
Kawasugi K
Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
[No Abstract] [Full Text] [Related]
34. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome-induced massive coagulopathy treated by recombinant human soluble thrombomodulin.
Hayashida K; Fujishima S; Nakaya N; Abe S; Shiroshita-Takeshita A; Hori S
Am J Emerg Med; 2013 Mar; 31(3):636.e1-3. PubMed ID: 23218866
[No Abstract] [Full Text] [Related]
36. [Effect of recombinant human soluble thrombomodulin in patients with solid carcinoma with DIC].
Asano Y; Kashiwagi S; Shibutani M; Yamazoe S; Noda S; Sakurai K; Nagahara H; Kimura K; Kawajiri H; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohtani H; Takashima T; Yashiro M; Onoda N; Maeda K; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2503-5. PubMed ID: 25731571
[TBL] [Abstract][Full Text] [Related]
37. [Thrombomodulin-relationship thrombotic marker and therapeutic effect].
Nomura S
Rinsho Byori; 2011 Feb; Suppl 147():188-93. PubMed ID: 21761770
[No Abstract] [Full Text] [Related]
38. Use of recombinant thrombomodulin in disseminated intravascular coagulation complicated hemophagocytic lymphohistiocytosis.
Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Inazawa N; Tsutsumi H; Suzuki N
Indian J Pediatr; 2014 Mar; 81(3):288-91. PubMed ID: 23912823
[TBL] [Abstract][Full Text] [Related]
39. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis.
Ogawa Y; Yamakawa K; Ogura H; Kiguchi T; Mohri T; Nakamori Y; Kuwagata Y; Shimazu T; Hamasaki T; Fujimi S
J Trauma Acute Care Surg; 2012 May; 72(5):1150-7. PubMed ID: 22673239
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis.
Yamakawa K; Murao S; Aihara M
Thromb Haemost; 2019 Jan; 119(1):56-65. PubMed ID: 30597500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
